Fluorofenidone-d3
Fluorofenidone-d3 (AKF-PD-d3) is deuterium labeled Fluorofenidone (AKF-PD). Fluorofenidone is an orally active compound with anti-fibrotic, antioxidant, and anti-inflammatory pharmacological effects. Fluorofenidone downregulates the expression of ACSL4, upregulates GPX4 expression and inhibits the NF-κB signaling pathway to alleviate inflammation and fibrosis. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice. Fluorofenidone demonstrates protective effects against chronic lung injury in mice. Fluorofenidone can be used for the study of chronic obstructive pulmonary disease (COPD), pulmonary interstitial fibrosis (PIF) and non-small cell lung cancer (NSCLC)[2][3].
Product Specifications
Product Name Alternative
AKF-PD-d3
UNSPSC
12352005
Target
ERK; Isotope-Labeled Compounds; NF-κB; TGF-beta/Smad
Type
Isotope-Labeled Compounds
Related Pathways
MAPK/ERK Pathway; NF-κB; Others; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Solubility
10 mM in DMSO
Smiles
O=C1C=CC(C)=CN1C2=C([2H])C=C([2H])C(F)=C2[2H]
Molecular Formula
C12H7D3FNO
Molecular Weight
206.23
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
1-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-2-iodoethanone
